Management of Diarrhea After Biliary Stenting in Stage 4 Cholangiocarcinoma

Metal stent occlusion can cause complex biliary obstruction and sepsis, which may present with diarrhea as part of systemic illness, according to the European Society of Gastrointestinal Endoscopy 1
If stent occlusion is identified and estimated survival exceeds 6 months, replacement with a new metal stent is favored, as recommended by the American Gastroenterological Association 1, 2

Secondary Considerations: Bile Acid Malabsorption

Consider bile acid sequestrants (cholestyramine 4g with meals) as empiric therapy for bile acid diarrhea, as suggested by the National Institute of Diabetes and Digestive and Kidney Diseases 1

Do not attribute diarrhea to "expected side effects" without imaging confirmation of stent patency, as stent occlusion requires urgent intervention, according to the American College of Gastroenterology 1, 2
Metal stents are strongly preferred over plastic stents in stage 4 patients with life expectancy >6 months, as they have lower occlusion rates and fewer re-interventions, as recommended by the European Society of Gastrointestinal Endoscopy 1, 2
Endoscopic ultrasound-guided biliary drainage (EUS-BD) should be preferred over percutaneous transhepatic biliary drainage (PTBD) if ERCP fails, as EUS-BD has better clinical success rates and lower adverse events, according to the American Society for Gastrointestinal Endoscopy 2

The goal of palliative drainage is to enable systemic chemotherapy administration, which requires bilirubin reduction to compatible levels, as recommended by the National Comprehensive Cancer Network 2, 5

Patients with stents require close monitoring for recurrent sepsis, biliary obstruction, and stent occlusion, as these are common causes of morbidity and mortality beyond disease progression itself, according to the American Gastroenterological Association 1, 3